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ABSTRACT
Introduction: Non-melanoma skin cancer is
the most common malignancy worldwide.
Differentiating between malignant and benign
skin tumors, however, can be challenging. As a
result, various auxiliary tools have been
developed to aid in the diagnosis of cutaneous
neoplasms. Here, skin tumors were investigated
through analysis of their digital image
histograms and spectroscopic response under
ultraviolet (UV) and white light-emitting diodes
(LEDs).
Methods: Fifty tumoral lesions were
spectroscopically and histologically studied. For
optical studies, UV at 375 nm and white LEDs
were used to illuminate the lesions. Commercial
cameras were used for imaging, and a miniature
spectrometer with a bifurcated optical fiber was
used for spectroscopic measurements.
Results: In this study, the intensity histograms
of the images taken under white and UV
illumination and the spectroscopic response
under white light showed clear differences
between pigmented basal cell carcinoma
(BCC), intradermal melanocytic nevus (IDN),
and melanoma lesions for skin phototypes III
and IV. However, there was little difference in
their spectroscopic response to the UV LED.
Conclusion: We found differences in the
intensity and shape of diffuse reflectance
spectra of pigmented BCC, IDN, and melanoma
lesions in patients with skin phototypes III and
IV. Also, images taken under UV and white light
were helpful for differentiation of these
pigmented lesions. Additional research is
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needed to ascertain the clinical utility of these
tools for skin cancer diagnosis.
Keywords: Digital images; Melanoma; Skin
cancer; Spectroscopy
INTRODUCTION
Skin cancer is the most common malignancy
worldwide [1], and can be classified into two
groups: non-melanoma skin cancer (NMSC) and
melanoma. Of the former, 95% of cases are basal
cell carcinoma (BCC) or squamous cell
carcinoma (SCC), although other, rare
malignant skin tumors also belong to the
NMSC classification [2].
Non-melanoma skin cancer is the most
common type of cancer in white populations
[3]. In Mexico, the incidence of NMSC is
thought to be underreported, as it ranks third
in overall incidence, after lung and cervical
cancer, according to a 2008 report by the
National Cancer Institute. Skin cancer ranks
first in consultations among men and fourth
among women [4].
In BCC, the affected skin areas are primarily
those that are exposed. Though it progresses
slowly, BCC is locally aggressive and
destructive; however, metastasis is rare (only
0.05% of cases) [5]. The SCC type is most
common on the face and lower extremities,
and the risk of metastasis is*5% [6]. In a study
of clinical–pathological concordance conducted
in our department, SCC and BCC were found to
be the cancers most frequently confused with
one another [7].
Melanoma, on the other hand, has seen the
greatest increase per year worldwide [8]. In
Mexico, it is estimated to occur at a rate of 1
in 100,000, but the actual figure is likely higher
due to underreporting [9]. Although
superficially spreading melanoma is the most
common subtype in whites [8], a study
performed in the Hospital General Manuel Gea
Gonza´lez in Mexico City found that acral
lentiginous melanoma was the most frequent
subtype in the studied population [9].
The differential diagnosis of skin cancer
includes common benign neoplasms such as
seborrheic keratosis (SK) [10] and melanocytic
nevi. Precursor lesions, such as actinic keratosis
(AK) [11], are also a differential diagnosis of SCC
in situ, and in some studies even represent an
emerging SCC [3]. Pigmented epidermal tumors
can also be confused with lentigo maligna.
There are several auxiliary noninvasive
methods for the clinical diagnosis of skin
cancer. One such method is dermoscopy,
which increases diagnostic accuracy from 5 to
30% over visual inspection; nonetheless, it
requires expert evaluation [12, 13]. Finally,
histopathology is the gold standard for
diagnosis, but it is an invasive method.
In efforts to improve diagnosis, many new
devices and tools have been developed,
including reflectance confocal microscopy
(RCM), and fluorescence, Raman, and
reflectance spectroscopy, with promising
results [14–16]. Specifically, RCM is a
noninvasive method for real-time evaluation
of skin lesions, similar to histological images
[15]. However, this technique requires special
training and is expensive [17]. Diffuse
reflectance spectroscopy and fluorescence
spectroscopy operate based on light–matter
interaction, and both are promising
noninvasive tools for the diagnosis of cancer
[18, 19]. Their basic premise is that the emission
and scattering of light depends on the
composition and cell structure of tissues. Skin
lesions cause a change in composition and cell
structure, and thus produce a change in light
scattering as well as in fluorescence emission.
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Various investigations of biological tissue have
reported the use of diffuse reflectance and
fluorescence spectroscopy [20–23]. Pilot studies
have shown that fluorescence intensity is
greater at higher concentrations of skin
melanin. Furthermore, spectral distribution
patterns have been found to vary for different
types of skin lesions [24]. In addition, capturing
images of skin lesions using UV fluorescence
can reveal relevant information not easily
obtained under white light [25].
The purpose of this study was to take
advantage of the fluorescence and diffuse
reflectance of the skin tissue as reflected in the
red, green, and blue (RGB) histograms of images
obtained by a digital camera. This study can
thus shed light on the utility of these
techniques as noninvasive diagnostic aids in
NMSC and melanoma, and their primary
differential diagnoses.
METHODS
Our potential sample included patients from
the dermatology outpatient department at the
General Hospital ‘‘Dr. Manuel Gea Gonza´lez’’ in
Mexico City, who received a diagnosis of skin
cancer or other benign skin tumors, and were
scheduled for an incisional or excisional biopsy
during the period between October 2013 and
April 2014. Patients who signed the informed
consent form and attended the spectroscopy
measurement and lesion photography sessions
were included in the study. Patients who had no
histopathological results were excluded from
the sample, as were those who did not sign the
informed consent form.
The equipment used in this study included a
Sony Cyber-shot DSC-HX200V digital camera
with a CMOS sensor, 18.2 million effective
pixels in each picture, and a 309 optical
zoom. The images were stored on a secure
digital (SD) memory card and were later
downloaded to a computer for processing. In
addition, a Nikon D5100 camera was used for
taking digital images. This camera has CMOS
sensors, with a resolution of 16.2 megapixels
and 39 optical zoom. An SD card was likewise
used for image storage.
For spectroscopic measurements, a miniature
spectrometer USB4000-VIS-IR and a bifurcated
optical fiber QR400-7-UV/VIS (both Ocean
Optics, Inc., Dunedin, FL, USA) were used. In
addition, a laptop with National Instruments
LabVIEW 2010 software installed was used to
save the data.
For spectroscopic measurements and
imaging, light-emitting diodes (LEDs) were
used. These included LEDs emitting white
light in a range of 450–750 nm (LED-P3
W200-120/41SiLed Int.) and an LED emitting
ultraviolet light at a nominal wavelength of
365 nm, with 20-nm full width at half
maximum (FWHM) bandwidth (NCU033AT,
Nichia Corp.). An appropriate current source
was designed and built to feed the LEDs, which
yielded maximum radiation intensity of 1.6 and
1 W for white and UV light, respectively. For
imaging under white light, two illumination
panels of ten white LEDs each were mounted
and used to homogeneously illuminate the
lesion to be photographed, placing the panels
in a vertical position at a maximum distance of
50 cm from the studied area. The photographs
under UV light were taken using one UV LED
located 20 cm from the lesion. In all cases, LEDs
were built on aluminum heat sinkers. The
images were taken in a dark room, where the
only sources of light were those designed for
this study. Care was taken to position the light
sources and the camera so as to minimize the
presence of shadows in the images.
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For the clinical diagnosis, the study
procedure consisted in taking photographs
with a DermLite II Hybrid dermatoscope
under white light illumination. In addition,
images were captured with the digital cameras
used in this study under the two light
conditions described above.
For each recorded photograph, a lesion area
was selected and its RGB histograms were
processed, as follows: the total intensity
(corresponding to the total number of pixels
in the selected area for a given color) was
taken as the sum of the areas of all histogram
bins. The area of each bin was calculated as
the number of pixels in the bin
(corresponding to frequency) multiplied by
the bin width (corresponding to an intensity
range). Subsequently, the intensities of the
three RGB histograms were added to obtain
the total area intensity. As an example, the
user interface developed to process the
recorded digital images of skin lesions is
presented in Fig. 1. The left side of the
figure displays the lesion area selected from
the original digital image presented in the
rightmost part of the figure, together with the
matching RGB histograms. The digital image
corresponds to a foot lesion, clinically
diagnosed as an acral nevus, photographed
under white light.
For comparison, a region in the same area as
the lesion, but of a healthy neighboring zone,
was selected from the image (as seen in the
central column of Fig. 1). This area was
subjected to the same RGB intensity
evaluation. Using the healthy perilesional skin
intensity as reference, the percentage change in
lesion intensity was then evaluated.
In Fig. 1, the total RGB intensities are shown
in the lower right corner, while the
identification of the patient appears in the
upper right corner of the figure.
Fig. 1 Processing of the digital image of a toe lesion, taken under white light. Images of the lesion and the perilesional zone,
together with their respective RGB histograms, are also shown
318 Oncol Ther (2016) 4:315–331
Figure 2 shows images and histograms
recorded for the same toe lesion as before, but
this time using UV illumination.
For spectroscopic measurements, the LEDs
(one white or one UV LED) were coupled to the
bifurcated optical fiber, and the latter was
connected to the spectrometer through a
subminiature version A (SMA) connector.
Prior to each set of spectroscopic
measurements, the noise spectrum was
measured by placing the optical fiber probe on
the tissue in the absence of any excitation light.
The spectrum thus obtained was then
subtracted from every measured spectrum.
Spectra were recorded by placing the optical
fiber probe on at least three points of the lesion,
on the surrounding tissue, and finally on the
normal skin of the inner arm, which was chosen
as a control because it typically shows uniform
optical patterns. The irradiation power of the
light source was set to 1.5 mW, and the
spectrometer was configured with a 100-ms
integration time. Spectra were smoothed using
a fourth-order Savitzky–Golay filter to remove
high-frequency noise caused by the
spectrometer.
For each patient, a description of the lesions,
the clinical and histological diagnosis, the
gathered spectra, and the photographs were
recorded and entered into a database developed
in MATLAB [26].
Skin lesions were organized into six groups
according to the histology report: BCC, SCC,
melanoma, SK, melanocytic nevi, and other. In
addition, the patients were divided into groups
by Fitzpatrick skin phototype.
For all analyzed lesions, a corresponding
biopsy and histopathology study report was
performed, which was used as validation of the
optical results of the present study.
Fig. 2 Processing of digital image of a toe skin lesion under UV light. Images of the lesion and the perilesional zone are also
shown, with their respective histograms
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Compliance with Ethics Guidelines
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
2013. Informed consent was obtained from all
patients for inclusion in the study.
RESULTS
Fifty patients who were scheduled for biopsy
signed the informed consent form and
participated in the photography and
spectroscopy measurement sessions. From
these 50, nine patients were ultimately
excluded because their biopsy procedures were
cancelled. For one patient, the cancellation
occurred due to clinical improvement with
medical treatment, and the lesion was found
to be inflamed SK, while the remaining eight
patients did not attend their biopsy
appointments. Thus, data were collected from
41 patients, including 29 women and 12 men.
The mean age of the patients was 63.7 years,
with a median age of 67 years and standard
deviation (SD) of 15.85 years. A total of 50
lesions were analyzed (some patients had more
than one lesion). On the Fitzpatrick scale, 20
patients were classified as having skin
phototype IV (48.8%), 19 as phototype III
(46.3%), one as phototype II (2.4%), and one
as phototype V (2.4%). There were no patients
with skin phototypes I or VI.
As confirmed by histopathological studies,
BCC was the most common lesion, present in 15
of the 41 cases. Of these, nine were pigmented.
Melanocytic nevi were the next most common
tumor, with 11 cases. These included nine
intradermal nevi (IDN), one cellular blue nevus,
and one acral nevus. All nine cases of IDN were
pigmented lesions. The other reported skin
lesions comprised seven SCC, five melanomas,
four SK, one basal squamous carcinoma, one
trichofolliculoma, one venous lake, one severe
solar elastosis, one lymphocytoma cutis, one
sebaceous hyperplasia, one keloid, and one
proliferation of atypical melanocytes.
The clinical differential diagnoses of BCCwere
SK, IDN, sebaceous hyperplasia, SCC, and MM.
Some SCCs were diagnosed as hypertrophic AK,
irritated SK, or keratoacanthoma. The clinical
differential of basal squamous carcinoma and
venous lake was BCC. A typical melanocytic
proliferation was classified as acral nevus.
Diffuse Reflectance Spectroscopy Under
White Light
Because of the large number of lesions
investigated, and given the fact that the main
interest of the study was centered on pigmented
lesions, the following sections will focus
primarily on cases related to BCC (9), IDN
(10), and melanoma (4) lesions.
Figure 3 shows the diffuse reflectance spectra
of the normal cheek and forehead tissues in
patients with skin phototypes III and IV. The
curves are the average spectra for all sampled
patients in each skin phototype group. The
vertical bars in the graphics account for the
observed standard deviations. It is clear from
the figure that there is a distinct difference in
the diffuse reflectance spectra of the forehead
for the two phototypes.
In Fig. 4A, B, the average diffuse reflectance
spectra of pigmented BCC, IDN, and melanoma
cutaneous lesions obtained under white LED
light are displayed separately for patients with
skin phototypes III and IV, respectively. Typical
points of hemoglobin absorption at 545 and
320 Oncol Ther (2016) 4:315–331
575 nm appear in the diffuse reflectance spectra
for all except pigmented IDN. From Fig. 4, it is
clear that the spectral shape of each skin lesion
is different, irrespective of the phototype. These
spectra can be differentiated from one another
by their intensity, especially in the range of 550
to 725 nm. It is worth noting that for BCC, the
intensity in phototype IV is higher than that in
phototype III, while for IDN the intensities are
similar between phototypes.
Of note, the general trend of the curves in
Fig. 4 agrees with previous reports by Borisova
et al. [27, 28], which showed that the intensity
of the reflectance spectra in the region between
550 and 725 nm increased in the order
melanoma\BCC\IDN\normal skin.
Fig. 3 Cheek (A) and forehead (B) diffuse reﬂectance spectra for patients with skin phototypes III and IV
Fig. 4 Diffuse reﬂectance spectra of cutaneous pigmented IDN, BCC, and melanoma lesions in patients with skin
phototypes III (A) and IV (B)
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Spectroscopic Response Under UV Light
The spectral emission of the UV LED used in the
study is shown in Fig. 5. A high emission peak is
observed extending from 325 to 412 nm, with a
maximum at 375 nm instead of 365 nm, as was
stated in the LED datasheet supplied by the
manufacturer. A soft emission is also present
from*410 to 800 nm, with a local maximum at
around 500–550 nm, as shown in the inset of
Fig. 5, where a zoom image of the appropriate
region of the emission spectrum is plotted.
This soft emission was detected in all
spectroscopic measurements, overlapping with
the possible tissue fluorescence in this same
wavelength region, as can be seen in Fig. 6,
where the spectra observed for several skin
lesions and their surrounding region are
displayed separately for patients with skin
phototypes III and IV. The assumption of the
fluorescence emission in this region is
supported by previous reports [28] in which
the same fluorescence distinctive mark was used
to discriminate between BCC and SCC lesions.
Unfortunately, with the UV source used in this
work, it was either impossible or very difficult to
attempt such differentiation.
For the sake of comparison, the measured
average spectra for the forearm region are
plotted in Fig. 6. Here, the previously mentioned
soft emission peak from the source is seen as a
reflection from the normal skin. In the same
wavelength region, some fluorescence should be
expected [28], but it is difficult to resolve it from
the former. In any case, it is evident from Fig. 6
that for the spectra of all studied lesions—
identified in the graphics as intradermal nevus
Fig. 5 Measured spectral emission of the NCU033AT
ultraviolet LED (Nichia Corp.). The inset is a zoom of the
right tail of the UV main peak
Fig. 6 Measured spectra under UV illumination for pigmented skin lesions in patients with skin phototypes III (A) and IV (B)
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(IDN), basal cell carcinoma (BCC), andmelanoma
(MEL)—the intensity in the wavelength region
around 500 nm is much lower than that in the
nearby healthy zone, leading to the conclusion
that either the fluorescence ismuchweaker or the
peak intensity of the soft emission is absorbed
more strongly in the lesions than in the
perilesional zone, or both. This characteristic in
common to all lesions, but the differences in the
spectra are not sufficient to unequivocally
differentiate one lesion from another, nor are
there clear differences between the spectra of the
lesions in the region of larger wavelengths,
between 575 and 800 nm.
This analysis leads us to conclude that UV
spectroscopy performed with the UV source
described above is not an effective tool for the
differential diagnosis of IDN, BCC, or melanoma.
However, the distinct absorption of the lesions in
comparison to the neighboring healthy skin tissue
points to the possibility of obtaining high-contrast
images using this particular UV LED.
Such result was confirmed for the lesion
images obtained under UV light, where the
lesion edges were identified more precisely than
in the photos taken under white light, even for
non-pigmented lesions.
As an example, in Fig. 7A, B, photographs
taken under white and UV light from a
non-pigmented BCC in the nose are presented,
together with the UV spectra measured in one
point in the perilesional region and five points
Fig. 7 Digital images of a non-pigmented BCC taken under white LED light (A) and UV light (B). C Spectra measured on
the lesion and on the perilesional skin using the UV light source
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on the tumor. The displayed BCC spectrum is
the average of the five measured curves. In the
UV image, the lesion is evident, with
well-defined edges, whereas these are hardly
seen in the white light photograph. In the
measured BCC spectrum in Fig. 7C, the
previously mentioned absorption in the region
from 425 to 600 nm is evident.
UV and White Light Images
From the recorded images, it was necessary to
exclude lesions that were in hairy regions, due
to the technical difficulties encountered for
image analysis. In addition, one case of SCC
was excluded because of significant bleeding,
which made it impossible to take an appropriate
photograph. One other case was excluded due
to poor image quality. Thus, a total of 39 lesions
were ultimately considered.
Figure 8 shows someexamples of theobtained
images. Figure 8A, B shows photographs of a
diagnosed melanoma taken under white and UV
light, respectively. Figure 8C displays a BCC
recorded under white illumination, while
Fig. 8D depicts the same lesion, but
photographed using UV light. As stated above,
lesion details that were not easily seen in white
light images were able to be detected in UV
images.
Fig. 8 Images of some of the examined skin lesions. Melanoma under white light (A) and under UV illumination (B). BCC
under white (C) and UV (D) light
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It must be noted that artifacts were present
in several UV images, as in the case of Fig. 8D,
where fiber scraps, presumably from the gauze
used to clean the lesion, are clearly observed.
Such fibers could also come from clothing or
other objects used by patients, and this should
be taken into account in future studies.
All images were subjected to intensity
analysis. Table 1 shows the variation among
lesions in terms of percentage change in
intensity relative to healthy tissue in patients
with skin phototype IV. With the exception of
SCC under UV light, the light intensity from the
lesions was lower than that from healthy tissue,
which shows that the percentage intervals for
white light can differentiate melanoma from
melanocytic nevi and SCC. Under UV light, the
intensity was able to differentiate melanoma
from pigmented BCC and SCC, but not from
pigmented melanocytic nevi. In addition, SCC
was able to be differentiated from all other
lesions under UV light. This was not observed
under white light, where there were no
differences between SCC and non-pigmented
melanocytic nevi.
Table 2 shows the variation among lesions in
terms of percentage change in intensity relative
to healthy perilesional tissue in patients with
skin phototype III. The data here show that
under both white and UV light, only SCC was
able to be differentiated from the other studied
lesions. Pigmented melanocytic nevi and
pigmented BCC were differentiated to a lesser
extent, due to the overlapping of intervals.
Unfortunately, we did not obtain any
information about melanoma in this skin
type, in which a lower range of variation
would be expected in comparison to skin
phototype IV.
One melanoma occurred in a patient with
skin phototype V, as shown in Table 3. In this
case, the difference in light intensity was
lower than that in patients with skin type
IV, which can be explained if we consider that
skin phototype V represents a darker skin
color, so the difference in light intensity
between the lesion and perilesional tissue is
smaller.
Finally, one skin phototype II patient with
BCC diagnosis showed poor pigmentation in
the lesion, which made it scarcely visible.
However, sporadic small dark spots were
detected in the area of the lesion. The
intensity change values are reported in Table 4.
A more statistically formal test was
performed to determine whether the analyzed
skin lesions could be differentiated using the
recorded digital images and their RGB intensity
histograms. For this, the ratio of the total area
intensity of the lesion in the image to the total
intensity of a nearby region of healthy tissue of
the same area was calculated, and the values of
such ratios were grouped according to lesion
type, separately for phototypes III and IV.
Table 1 Percentage change in total intensity (measured from digital image RGB histograms) of lesions in patients with skin
phototype IV, relative to the intensity of perilesional healthy tissue
Skin lesion Intensity change under white light (%) Intensity change under UV light (%)
Melanoma -88 to -62 -78 to -67
Pigmented IDN -61 to -25 -74 to -32
Non-pigmented IDN (one patient) -15 -4
Pigmented BCC -70 to -34 -57 to -34
SCC -23 to -5 7 to 446
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In Figs. 9 and 10, the mean values of the
intensity ratio for each group are plotted,
together with a bar indicating the
corresponding standard deviation (SD).
Figure 9 shows the intensities gathered from
images taken for phototype III patients, while
Fig. 10 presents the intensity relations in images
taken in phototype IV patients. In both figures,
graphic A corresponds to images taken under
white light, and graphic B matches UV images.
The aforementioned observation of lower
intensity in the lesion than in the surrounding
healthy tissue—i.e. intensity ratio of less than
1.0—can be observed in Figs. 9 and 10 for all
analyzed lesion groups except for SCC under UV
light in phototype IV and with both types of
illumination in phototype III.
The intensity ratio samples were analyzed
using one-way analysis of variance (ANOVA) to
check the null hypothesis that the samples
being compared have the same mean
statistically, or equivalently, to check whether
the samples come from the same population.
An ANOVA p value less than 0.05 indicates that
the null hypothesis must be rejected with a 95%
significance level, thus indicating that the
samples come from different populations. In
other words, an ANOVA p value lower than 0.05
would indicate that the lesions of the different
groups can be differentiated from one another
using the digital image intensity ratios between
the lesion and its surrounding healthy region as
the analysis variable.
In Figs. 9 and 10, the letters next to each
lesion-type SD bar indicate the kinds of lesions
that can be discriminated from the lesion in
question, following the scheme described in the
figure captions. Looking at these letters, it
becomes evident that the conclusions drawn
from Tables 1 and 2 are confirmed.
In patients with skin phototype III (Fig. 9),
IDC can be discriminated from all other lesions
under both white and UV light; the same
statement is valid for SCC under white light,
Table 2 Percentage change in total intensity between lesions and perilesional tissue in patients with skin phototype III
Skin lesion Intensity change under white light (%) Intensity change under UV light (%)
Pigmented IDN -57 to -45 -78 to -52
Pigmented BCC -55 to -10 -56 to -28
Non-pigmented BCC -24 to -4 -57 to -17
SCC 9 to 48 53 to 157
SCC in situ -44 to 3 -39 to 52
Table 3 Percentage change in total intensity in melanoma (one patient with skin phototype V)
Patient number Intensity change under white light (%) Intensity change under UV light (%)
20 -46 -38
Table 4 Percentage change in total intensity in BCC (one patient with skin phototype II)
Patient number Intensity change under white light (%) Intensity change under UV light (%)
14 -11 -65
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whereas under UV illumination, SCC can be
differentiated from BCC (pigmented and
non-pigmented) and from IDN, but not from
in situ SCC. On the other hand, Fig. 9 shows
that pigmented and non-pigmented BCC
cannot be discriminated using the proposed
method, regardless of the illumination type.
For phototype IV, shown in Fig. 10, the
method allows differentiation of melanoma
from SCC and IDN under white light, and
from BCC and SCC under UV light. For its
part, SCC can be differentiated from all other
lesions under white light but not under UV
light.
Fig. 9 Total intensity ratios of digital images taken in
patients with skin phototype III under white light (A) and
UV light (B). P-BCC pigmented basal cell carcinoma,
NP-BCC non-pigmented basal cell carcinoma, SCC
squamous cell carcinoma, IS-SCC in situ squamous cell
carcinoma, IDN intradermal nevus. a p\0.05, compared
to P-BCC; b p\0.05, compared to NP-BCC; c p\0.05,
compared to SCC; d p\0.05, compared to IS-SCC;
e p\0.05, compared to IDN
Fig. 10 Total intensity ratios of digital images in patients
with skin phototype IV, recorded under white (A) and UV
(B) light. BCC basal cell carcinoma, SCC squamous cell
carcinoma, MM malignant melanoma, IDN intradermal
nevus. a p\0.05, compared to BCC; b p\0.05,
compared to SCC; c p\0.05, compared to MM;
d p\0.05, compared to IDN
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DISCUSSION
Several research groups have studied the use of
fluorescence for the detection and
differentiation of skin cancer [19, 27–30].
Diffuse reflectance spectroscopy has also been
used to study cutaneous malignancies; Borisova
et al. [28] reported spectra for BCC and
melanoma lesions similar to those shown in
Fig. 4 of this paper. Cordo et al. [31] applied
diffuse reflectance spectroscopy from 550 to
1000 nm in healthy skin (inner and outer
forearm), in addition to different pigmented
skin lesions and their adjacent areas. The
authors found that the major differences were
in the wavelength of maximum reflectance and
in the slope of the spectral curves in the
wavelength interval between 760 and 910 nm.
The principal contribution of the present
study is the application of UV and white light
LEDs to obtain color images whose histograms
help to differentiate skin tumors. Although
multispectral images at different spectral bands
in the visible region of the electromagnetic
spectrum [32] and at 360 nm in the UV range
[33] have been used for melanoma diagnosis, as
well as white light digital image processing for
differentiation of melanoma and
non-melanoma skin lesions [34–36], to our
knowledge, this is the first time that digital
image intensity RGB histograms have been
successfully used for the evaluation and
discrimination of skin cancer lesions.
With the exception of SCC, in all analyzed
cases the intensity of the reflectance shown in
the spectra and in the image RGB histograms
was higher for the healthy tissue than for the
lesions. An important finding was that the
results varied according to patient skin
phototype. In addition, lower intensity was
observed for pigmented versus non-pigmented
lesions, and the reflected intensity of melanoma
was lower than that of the other lesions.
Although we examined only a small number
of lesions, this study produced important data
to consider for subsequent studies.
The results for images recorded under white
light revealed a difference between melanoma
and melanocytic nevi. In addition, in the
images taken under UV light at 375 nm, it was
possible to differentiate between melanoma and
pigmented BCC. We propose this method as an
auxiliary diagnostic tool, prior to biopsy, for
distinguishing among these pigmented entities.
However, we did not find patterns in this study
to support differentiation between BCC and
pigmented melanocytic nevi, and we suggest
that further studies are needed.
An advantage of the imaging study is that
the area for analysis can be chosen with great
precision. There is no influence of pressure on
the tissue, and different areas (lesion,
perilesional, and apparently healthy skin)
can be compared under the same light. This
could help in identifying lesions that are
invisible to the naked eye, and in guiding
the clinician’s choice of biopsy site, especially
when using images of the same region
obtained with the two different light sources.
This finding is in accordance with the recently
published study by Nguyen et al. [32, 37]
regarding the use of intraoperative artificial
fluorescent markers (‘‘fluorescence-guided
surgery’’) to support the delineation of tumor
margins.
One drawback that became apparent in the
analysis of fluorescence images was that the use
of socks, cotton, or bandages could leave
protruding millimeter fibers in the UV image;
this fact should be taken into consideration in
future studies. In addition, larger tumors and
those in areas with hair presented difficulties in
obtaining pictures and performing intensity
measurements.
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CONCLUSION
In this study, we found that the diffuse
reflectance spectra of pigmented BCC, IDN,
and melanoma cutaneous lesions in patients
with skin phototypes III and IV were useful in
differentiating between these lesions. White
light images could thus serve as an auxiliary
tool for clinically differentiating between BCC,
IDN, and melanoma cutaneous lesions in these
patients. The UV light images at 375 nm were
able to differentiate melanoma from pigmented
BCC.
The results from this pilot study may pave
the way for further research to document the
value of these new tools in the clinical diagnosis
of melanoma and non-melanoma skin cancer.
These methods are noninvasive, affordable, and
easy to use, and thus could be useful in skin
cancer treatment centers.
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